are not in the subsidiarys functional 
currency). The Group estimates the IBR using observable inputs (such as market interest rates) when available and is required to make 
certain entity-specific estimates (such as the subsidiarys stand-alone credit rating). === Page 147 ===
IBA Annual Report 2023 
144. 5.4. ASSOCIATES AND JOINT VENTURES 
Associates and Joint Ventures are listed in note 
12.2 
and 
are 
Cyclhad 
SAS, Normandy 
Hadrontherapy SAS, Normandy Hadrontherapy 
SARL and PanTera SA/NV.